NCT06375954
EUS-guided CDS vs ERCP as First Line in Malignant Distal Obstruction in Borderline Disease (CARPEDIEM-2 Trial) No drug interventions treatment Not Available not_yet_recruiting NCT01695447
Duct-to-mucosa Versus Invagination for Pancreaticojejunostomy No drug interventions treatment Not Available unknown_status NCT05723705
Impact of a European Training Program for Robotic Liver Surgery (LIVEROBOT) No drug interventions Not Available Not Available not_yet_recruiting NCT01242605
ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer treatment 1 completed NCT05320497
Transparent Cap-assisted SpyGlass for Biliary Stricture No drug interventions device_feasibility Not Available unknown_status NCT04856761
A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection Not Available Not Available recruiting NCT04010071
Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors treatment 2 recruiting NCT03111732
Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC) treatment 2 completed NCT05190575
TST001 in Patients With CLDN18.2 Positive Previously Treated Advanced Biliary Tract Cancer treatment 2 completed NCT03427242
Apatinib for Advanced Biliary Carcinoma treatment 2 unknown_status NCT02829918
Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers treatment 2 completed NCT01758341
Radiofrequency Ablation for Malignant Biliary Obstruction No drug interventions treatment 4 completed NCT00939848
Cediranib Versus Placebo Plus Cisplatin/Gemcitabine Chemotherapy for Patients With Advanced Biliary Tract Cancers treatment 2 / 3 completed NCT04308174
Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer treatment 2 active_not_recruiting NCT00359320
A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy No drug interventions treatment Not Available terminated NCT04579380
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations treatment 2 active_not_recruiting NCT02715089
Precise Treatment in Hepatobiliary Cancers (PTHBC) No drug interventions Not Available Not Available unknown_status NCT00980889
RCT Steel (Wallstent®) vs Nitinol (Wallflex®) Bile Duct Stent for Palliation of Malignant Obstruction No drug interventions treatment 4 completed NCT04956640
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) treatment 1 / 2 recruiting NCT05520801
Primary Hepatobiliary Cancer Cohort of Central China No drug interventions Not Available Not Available recruiting NCT01962168
Evolution® Biliary Stent System Clinical Study No drug interventions Not Available Not Available completed NCT02255669
Fully Covered SEMS Versus Partially Covered SEMS With Anti-migration System for Malignant Distal Biliary Obstruction No drug interventions treatment Not Available unknown_status NCT02615210
Mid-Atlantic Research Group Single-Operator Cholangioscopic Assessment of Biliary Strictures No drug interventions diagnostic Not Available terminated NCT04566614
Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies No drug interventions Not Available Not Available recruiting NCT04352023
Analgesic Efficacy After Pancreatobiliary Surgery: Intravenous Versus Patient-controlled Epidural No drug interventions treatment 2 unknown_status NCT04584008
Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics No drug interventions treatment Not Available recruiting NCT04566133
Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC). treatment 2 terminated NCT03063554
EUS BD vs ERCP TP for Pancreatic Cancer No drug interventions treatment Not Available unknown_status NCT02821754
A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC) treatment 2 completed NCT00487851
Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-resectable Periampullary Cancer No drug interventions treatment 2 withdrawn NCT02784353
Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP Malignancy No drug interventions supportive_care Not Available completed NCT02809898
The Role of ctDNA and PBMC in Treatment of Biliary Tract Cancer No drug interventions Not Available Not Available unknown_status NCT00196105
Malignant Obstruction ZILVER Against Routine Therapy (MOZART I) No drug interventions treatment Not Available completed NCT03801083
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers No drug interventions treatment 2 recruiting NCT06375928
EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction in Resectable Disease (CARPEDIEM-1 Trial) No drug interventions treatment Not Available not_yet_recruiting NCT05237193
A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-up No drug interventions Not Available Not Available unknown_status NCT03504293
The Diagnostic Value of Combinatory EUS and ERCP in Unclear Lesions No drug interventions Not Available Not Available completed NCT03478488
Programmed Death Ligand (PD-L1) Combined With Chemotherapy for Patients With BTC treatment 3 active_not_recruiting NCT01543607
Endoscopic Therapy of Malignant Bile Duct Strictures No drug interventions treatment Not Available terminated NCT00422409
Endoscopic Stenting of Gastrointestinal Cancer No drug interventions treatment Not Available completed NCT05896956
The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Benign and Malignant Biliary Tract Diseases No drug interventions Not Available Not Available not_yet_recruiting NCT02558959
Second-line Irinotecan and Capecitabine Versus Irinotecan for Gemcitabine and Cisplatin Refractory Biliary Tract Cancer treatment 2 completed NCT03406299
Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer treatment 2 active_not_recruiting NCT05615818
Personalized Medicine for Advanced Biliary Cancer Patients treatment 3 recruiting NCT01853618
Tremelimumab With Chemoembolization or Ablation for Liver Cancer treatment 1 / 2 completed NCT04976634
Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Solid Tumors (MK-6482-016) treatment 2 recruiting NCT04595058
LAMS Choledochoduodenostomies: With or Without Coaxial Plastic Stent No drug interventions treatment Not Available completed NCT03875235
Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1) treatment 3 active_not_recruiting NCT04910386
Multicenter Phase 2 Study of Envafolimab in Biliary Tract Cancers treatment 2 not_yet_recruiting NCT01315522
Covered vs. Uncovered SEMS for Occluded Biliary Metal Stents No drug interventions treatment 4 completed NCT02900248
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice No drug interventions Not Available Not Available terminated NCT03101566
Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer treatment 2 completed NCT02943031
The Effect of Individualized Precision Therapy Programs in Patients With BTC No drug interventions treatment 4 unknown_status NCT03046862
Durvalumab(MEDI4736)/Tremelimumab in Combination With Gemcitabine/Cisplatin in Chemotherapy-naïve Biliary Tract Cancer treatment 2 active_not_recruiting NCT00268840
The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer treatment 2 completed NCT06375967
EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial) No drug interventions treatment Not Available not_yet_recruiting NCT01950572
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma No drug interventions Not Available Not Available recruiting NCT06037655
Chemotherapy Combined With Adebrelimab and Mecapegfilgrastim in Neoadjuvant Treatment of Potentially Resectable BTC No drug interventions treatment 2 not_yet_recruiting NCT05429203
Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope No drug interventions other Not Available recruiting NCT00174564
EXIBIT: Oxaliplatin in Biliary Tract Cancer treatment 2 completed NCT01731821
Nonstented Stump-closed vs Duct-to-Mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy No drug interventions treatment 3 completed NCT05935579
Durvalumab and Lenvatinib With or Without Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer treatment 2 recruiting NCT01595217
MRCP Diagnoses EHCC Better When Combined DWI No drug interventions diagnostic Not Available completed NCT01542281
Pre-habilitation to Improve Outcomes in Patients Undergoing Liver Resection for Cancer No drug interventions supportive_care Not Available unknown_status NCT02527824
Study of Oxaliplatin, Irinotecan, and S-1 in Biliary Tract Cancer treatment 2 unknown_status NCT02146703
Gemcitabine and S-1 for Advanced Biliary Tract Cancer treatment 2 completed